YOU ARE HERE:
Starting treatment news
page  of 15
 
Headline
Date
  Lack of perceived need for HIV treatment associated with poor adherence
06.01.09
  Adherence of 80-95% not good enough for long-term treatment success in British Columbia HIV patients
12.12.08
  Community support improves HIV treatment outcomes for patients in South Africa
09.12.08
  Universal testing and treatment could reduce new HIV infections in southern Africa by 95% in 10 years
26.11.08
  Treatment during primary HIV infection has limited benefit
24.11.08
  High rate of death amongst patients with HIV diagnosed late
20.11.08
  IL-2 provides quick ‘AIDS rescue’, but effect does not always last
17.11.08
  Treatment breaks set for a come-back?
12.11.08
  Kivexa downgraded to alternative status in revised US HIV treatment guidelines
05.11.08
  Enhanced Trofile assay better at identifying HIV tropisms, only slight impact on virologic outcomes
31.10.08
  Tenofovir/FTC more effective than abacavir/3TC in first-line boosted-PI regimens: meta-analysis
29.10.08
  Start treatment at CD4 cell counts below 500, says large cohort study
27.10.08
  No significant differences between elvucitabine and 3TC at 48 weeks
27.10.08
  Raltegravir non-inferior to efavirenz: 48 week, phase III results
27.10.08
  Once-daily darunavir (Prezista) approved for first-line use in United States
22.10.08
  Is there a role for tropism testing in routine HIV care?
22.10.08
  Low rate of spontaneous hepatitis C clearance in patients with HIV; early HIV treatment recommended for those with chronic hepatitis C infection
02.10.08
  Hypersensitivity testing for abacavir slightly more cost-effective than tenofovir use, if both drugs equally potent
30.09.08
  More evidence that antiretrovirals reduce the risk of non-HIV illnesses at lower CD4 cell counts
23.09.08
  Patients staying on first-line HIV treatment combinations for longer
16.09.08

page  of 15